Dr Denis Scanlon Bio for SPPS Symposium October 2013 He commenced work at the Howard Florey Institute in 1978 as a chemist and in 1981 he was seconded to ICI Pharmaceuticals at Alderley Edge in the UK where he was part of the team which performed the total chemical synthesis of the gene for human leukocyte interferon alpha. On his return from the UK he enrolled in a PhD at the Howard Florey Institute under Dr Geoff Tregear which he completed in 1984. He was part of the HFI relaxin group which successfully cloned and sequenced porcine, rat and human relaxin. After completion of his PhD he spent 2 years as a post-doctoral fellow at the Ludwig Institute for Cancer Research with Dr Richard Simpson in the Joint Protein Sequencing Laboratory (JPSL) where he set up the techniques of peptide and oligonucleotide synthesis within the Institute. In 1987 he became a founding staff member of Auspep Pty Ltd where he established and managed the custom peptide synthesis laboratory. In 1990 he was appointed as a Director of the company. He continued as a Director but in 1992 he moved to CSIRO AAHL in Geelong as Project Leader of the Protein Chemistry Laboratory working on Newcastle disease virus. He moved back to Auspep in 1995 and from 1995 to 1997 he worked in the capacity of Auspep Project Leader of a Corporate Research Project in collaboration with Queensland Institute of Technology. From 1998 until 2004 he continued with Auspep as Senior Chemist and Research and Development Manager. In 2005 he joined Peptide Solutions, a small start up company based at La Trobe University and established a small peptide synthesis facility working on N-methylation of peptide bonds. In 2006 he was appointed as the manager of the Research Transfer Facility at Bio21 Institute at the University of Melbourne where he managed a mass spectrometry, peptide synthesis and HPLC purification facility. In 2009 he moved to Adelaide and currently he holds an Adjunct Research Fellow position at the University of Adelaide.